Form 4 for EFX Equifax
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0001062993-23-021103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-17 | 2023-11-15 | EFX | KELLEY JOHN J III | EVP, CLO | S - Sale+OE | $199.52 | -48.2K | 32.4K | -60% | -$9.62M |
| DM | 2023-11-17 | 2023-11-15 | EFX | KELLEY JOHN J III | EVP, CLO | M - OptEx | $139.83 | +48.2K | 42.4K | New | +$6.74M |
| DM | 2023-11-17 | 2023-11-15 | EFX | KELLEY JOHN J III | EVP, CLO | M - OptEx | $0.00 | -48.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-15 | S | D | 13,123 | $200.97 | 13,900 | D | — | — | (F8) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.51 to $201.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Common | Common Stock | 2023-11-15 | S | D | 506 | $201.56 | 13,394 | D | — | — | (F9) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.54 to $201.56, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 3 | Common | Common Stock | 2023-11-15 | S | D | 5,365 | $199.91 | 27,023 | D | — | — | (F7) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.51 to $200.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 4 | Common | Common Stock | 2023-11-15 | M | A | 19,172 | $149.53 | 61,615 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 5 | Common | Common Stock | 2023-11-15 | S | D | 4,266 | $198.27 | 56,191 | D | — | — | (F5) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.47 to $198.465, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 6 | Common | Common Stock | 2023-11-15 | S | D | 753 | $196.88 | 60,457 | D | — | — | (F4) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.44 to $197.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 7 | Common | Common Stock | 2023-11-15 | S | D | 405 | $195.35 | 61,210 | D | — | — | (F3) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $195.02 to $195.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 8 | Common | Common Stock | 2023-11-15 | M | A | 13,150 | $127.37 | 26,544 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 9 | Common | Common Stock | 2023-11-15 | M | A | 15,899 | $138.45 | 42,443 | D | — | — | (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 10 | Common | Common Stock | 2023-11-15 | S | D | 23,803 | $198.96 | 32,388 | D | — | — | (F6) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.49 to $199.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 11 | Derivative | Stock Option/Right to Buy | 2023-11-15 | M | D | 15,899 | $0.00 | 0 | D | $138.45 · 2022-02-22 to 2025-02-22 | 15,899 Common Stock | |
| 12 | Derivative | Stock Option/Right to Buy | 2023-11-15 | M | D | 13,150 | $0.00 | 0 | D | $127.37 · 2022-02-22 to 2025-02-22 | 13,150 Common Stock | |
| 13 | Derivative | Stock Option/Right to Buy | 2023-11-15 | M | D | 19,172 | $0.00 | 0 | D | $149.53 · 2022-02-22 to 2025-02-22 | 19,172 Common Stock |